{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:15:51Z","timestamp":1791090951045,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1124\/jpet.108.138651","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T21:51:18Z","timestamp":1208296278000},"page":"178-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Effects of the \u03b23-Adrenergic Receptor Agonist Disodium 5-[(2 R)-2-[[(2 R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on Bladder Micturition Reflex in Spontaneously Hypertensive Rats"],"prefix":"10.1016","volume":"326","author":[{"given":"Lisa A.","family":"Leon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Laping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.R.","family":"Lashinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.138651_bib1","doi-asserted-by":"crossref","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, and Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187: 116\u2013126.","DOI":"10.1067\/mob.2002.125704"},{"key":"10.1124\/jpet.108.138651_bib2","doi-asserted-by":"crossref","unstructured":"Andersson KE and Wein AJ (2004) Pharmacology of the lower urinary tract: basic for current and future treatments of urinary incontinence. Pharmacol Rev 56: 581\u2013631.","DOI":"10.1124\/pr.56.4.4"},{"key":"10.1124\/jpet.108.138651_bib3","doi-asserted-by":"crossref","unstructured":"Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, and Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121\u2013136.","DOI":"10.1016\/S0031-6997(25)06780-8"},{"key":"10.1124\/jpet.108.138651_bib4","doi-asserted-by":"crossref","unstructured":"Clemow DB, McCarty R, Steers WD, and Tuttle1 JB (1997) Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourol Urodyn 16: 293\u2013303.","DOI":"10.1002\/(SICI)1520-6777(1997)16:4<293::AID-NAU5>3.0.CO;2-9"},{"key":"10.1124\/jpet.108.138651_bib5","doi-asserted-by":"crossref","unstructured":"Clemow DB, Spitsbergen JM, McCarty R, Steers WD, and Tuttle JB (1999) Altered NGF regulation may link a genetic predisposition for hypertension with hyperactive voiding. J Urol 161: 1372\u20131377.","DOI":"10.1016\/S0022-5347(01)61686-0"},{"key":"10.1124\/jpet.108.138651_bib6","doi-asserted-by":"crossref","unstructured":"Dmitrieva N and McMahon SB (1996) Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 66: 87\u201397.","DOI":"10.1016\/0304-3959(96)02993-4"},{"key":"10.1124\/jpet.108.138651_bib7","doi-asserted-by":"crossref","unstructured":"Ehlert FJ, Ahn S, Pak KJ, Park GJ, Sangnil MS, Tran JA, and Matsui M (2007) Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther 322: 631\u2013637.","DOI":"10.1124\/jpet.107.121756"},{"key":"10.1124\/jpet.108.138651_bib8","doi-asserted-by":"crossref","unstructured":"Frazier EP, Mathy MJ, Peters SLM, and Michel MC (2005) Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol? J Pharmacol Exp Ther 313: 260\u2013267.","DOI":"10.1124\/jpet.104.077768"},{"key":"10.1124\/jpet.108.138651_bib9","doi-asserted-by":"crossref","unstructured":"Frazier EP, Schoneider T, and Michel MC (2006) Effects of gender, age and hypertension on \u03b2-adrenergic receptor function in rat urinary bladder. Naunyn Schmiedebergs Arch Pharmacol 373: 300\u2013309.","DOI":"10.1007\/s00210-006-0077-y"},{"key":"10.1124\/jpet.108.138651_bib10","doi-asserted-by":"crossref","unstructured":"Hendley ED, Cierpial MA, and McCarty R (1988) Sympathetic-adrenal medullary response to stress in hyperactive and hypertensive rats. Physiol Behav 44: 47\u201351.","DOI":"10.1016\/0031-9384(88)90344-7"},{"key":"10.1124\/jpet.108.138651_bib11","doi-asserted-by":"crossref","unstructured":"Kaidoh K, Igawa Y, Takeda H, Yamazaki Y, Akahane S, Miyata H, Ajisawa Y, Nishizawa O, and Andersson KE (2002) Effects of selective \u03b22 And \u03b23-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol 168: 1247\u20131252.","DOI":"10.1016\/S0022-5347(05)64634-4"},{"key":"10.1124\/jpet.108.138651_bib12","doi-asserted-by":"crossref","unstructured":"Longhurst PA and Levendusky M (1999) Pharmacological characterization of \u03b2-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127: 1744\u20131750.","DOI":"10.1038\/sj.bjp.0702709"},{"key":"10.1124\/jpet.108.138651_bib13","doi-asserted-by":"crossref","unstructured":"Pandita RK, Persson K, and Andersson KE (1997) Capsaicin-induced bladder overactivity and nociceptive behaviour in conscious rats: involvement of spinal nitric oxide. J Auton Nerv Syst 67: 184\u2013191.","DOI":"10.1016\/S0165-1838(97)00116-1"},{"key":"10.1124\/jpet.108.138651_bib14","doi-asserted-by":"crossref","unstructured":"Persson K, Pandita RK, Spitsbergen JM, Steers WD, Tuttle JB, and Andersson KE (1998) Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol 275: R1366\u2013R1373.","DOI":"10.1152\/ajpregu.1998.275.4.R1366"},{"key":"10.1124\/jpet.108.138651_bib15","doi-asserted-by":"crossref","unstructured":"Rajasekaran M, Wilkes N, Kuntz S, and Albo ME (2005) Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats. Neurourol Urodyn 24: 295\u2013300.","DOI":"10.1002\/nau.20122"},{"key":"10.1124\/jpet.108.138651_bib16","doi-asserted-by":"crossref","unstructured":"Rozec B and Gauthier C (2006) \u03b23-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111: 652\u2013673.","DOI":"10.1016\/j.pharmthera.2005.12.002"},{"key":"10.1124\/jpet.108.138651_bib17","doi-asserted-by":"crossref","unstructured":"Schneider T, Hein P, Bai J, and Michel MC (2005) A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction. J Urol 173: 2178\u20132181.","DOI":"10.1097\/01.ju.0000158138.07187.f5"},{"key":"10.1124\/jpet.108.138651_bib18","doi-asserted-by":"crossref","unstructured":"Spitsbergen JM, Clemow DB, McCarty R, Steers WD, and Tuttle JB (1998) Neurally mediated hyperactive voiding in spontaneously hypertensive rats. Brain Res 790: 151\u2013159.","DOI":"10.1016\/S0006-8993(98)00061-4"},{"key":"10.1124\/jpet.108.138651_bib19","unstructured":"Steers W (2002) Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4: S7\u2013S18."},{"key":"10.1124\/jpet.108.138651_bib20","doi-asserted-by":"crossref","unstructured":"Su X, Leon LA, and Laping NJ (2008a) Role of spinal Cav2.2 and Cav2.1 ion channels in bladder nociception. J Urol 179: 2464\u20132469.","DOI":"10.1016\/j.juro.2008.01.088"},{"key":"10.1124\/jpet.108.138651_bib21","doi-asserted-by":"crossref","unstructured":"Su X, Ridel ES, Leon LA, and Laping NJ (2008b) Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension. Neurourol Urodyn 27: 249\u2013253.","DOI":"10.1002\/nau.20469"},{"key":"10.1124\/jpet.108.138651_bib22","doi-asserted-by":"crossref","unstructured":"Takeda H, Yamazaki Y, Igawa Y, Kaidoh K, Akahane S, Miyata H, Nishizawa O, Akahane M, and Andersson KE (2002) Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn 21: 558\u2013565.","DOI":"10.1002\/nau.10034"},{"key":"10.1124\/jpet.108.138651_bib23","doi-asserted-by":"crossref","unstructured":"Takeda H, Yamazaki Y, Akahane M, Igawa Y, Ajisawa Y, and Nishizawa O (2000) Role of the \u03b23-adrenoceptor in urine storage in the rat: comparison between the selective \u03b23-adrenoceptor agonist, CL316,243, and various smooth muscle relaxants. J Pharmacol Exp Ther 293: 939\u2013945.","DOI":"10.1016\/S0022-3565(24)39317-6"},{"key":"10.1124\/jpet.108.138651_bib24","doi-asserted-by":"crossref","unstructured":"Takeda M, Obara K, Mizusawa T, Tomita Y, Arai K, Tsutsui T, Hatano A, Takahashi K, and Nomura S (1999) Evidence for \u03b23-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288: 1367\u20131373.","DOI":"10.1016\/S0022-3565(24)38094-2"},{"key":"10.1124\/jpet.108.138651_bib25","doi-asserted-by":"crossref","unstructured":"Tong YC, Hung YC, Lin SN, and Cheng JT (1996) Comparisons of neurotransmitter concentrations in the synaptosomal preparation of the normotensive and hypertensive rat urinary bladder. Neurosci Lett 204: 141\u2013143.","DOI":"10.1016\/0304-3940(96)12339-9"},{"key":"10.1124\/jpet.108.138651_bib26","doi-asserted-by":"crossref","unstructured":"Vrydag W and Michel MC (2007) Tools to study \u03b23-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374: 385\u2013398.","DOI":"10.1007\/s00210-006-0127-5"},{"key":"10.1124\/jpet.108.138651_bib27","doi-asserted-by":"crossref","unstructured":"Woods M, Carson N, Norton NW, Sheldon JH, and Argentieri TM (2001) Efficacy Of The \u03b23-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166: 1142\u20131147.","DOI":"10.1016\/S0022-5347(05)65936-8"},{"key":"10.1124\/jpet.108.138651_bib28","doi-asserted-by":"crossref","unstructured":"Yamaguchi O and Chapple CR (2007) beta3-Adrenoceptors in urinary bladder. Neurourol Urodyn 26: 752\u2013756.","DOI":"10.1002\/nau.20420"},{"key":"10.1124\/jpet.108.138651_bib29","doi-asserted-by":"crossref","unstructured":"Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, et al. (2007) Defining overactive bladder as hypersensitivity. Neurourol Urodyn 26: 904\u2013907.","DOI":"10.1002\/nau.20482"},{"key":"10.1124\/jpet.108.138651_bib30","doi-asserted-by":"crossref","unstructured":"Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, and Ajisawa Y (1998) Species differences in the distribution of \u03b2-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124: 593\u2013599.","DOI":"10.1038\/sj.bjp.0701870"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524345069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524345069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.138651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:40:59Z","timestamp":1739986859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524345069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0022356524345069"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.138651","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1104994.562112","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the \u03b23-Adrenergic Receptor Agonist Disodium 5-[(2 R)-2-[[(2 R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on Bladder Micturition Reflex in Spontaneously Hypertensive Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.138651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}